Cargando…
Meissner awarded US$13.4mn to expand Covid-19-related capacity
Meissner Filtration Products has secured a US$13.4 million contract from the Bio-medical Advanced Research and Development Authority (BARDA) to expand the company's production capacity for products critical to Covid-19 vaccine and therapeutics manufacturing.
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205231/ http://dx.doi.org/10.1016/S1365-6937(21)00115-5 |